Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 3462
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT02603640 VIBRATIONS — " Virtual Brain "-Based Interpretation of Electrophysiolog… |
MRI scanning | Épilepsie | NA | COMPLETED | En attente / non publié | Norwegian University of Science a… | France · Assistance Publique Hôpitaux de Marseille, M… | 2016-03-18 → 2023-04-13 | Ouvrir |
| NCT01217021 Safety and Efficacy of Positron Emission Tomography (PET) Imaging With … |
[18F] MNI-558 | Alzheimer | Phase 1 | COMPLETED | En attente / non publié | Institute for Neurodegenerative D… | United States · Institute For Neurodegenerative Disor… | 2010-09 → 2011-03 | Ouvrir |
| NCT04327778 MAGE — Automate Music Therapy for the Management of Behavioral Disorder… |
Music Therapy | Alzheimer | NA | WITHDRAWN | En attente / non publié | Mayo Clinic | Non communiqué | 2021-08-09 → 2021-08-09 | Ouvrir |
| NCT01119638 EscBPSD — Escitalopram Treatment for BPSD in Alzheimer's Disease in Com… |
escitalopram | Alzheimer | Phase 4 | COMPLETED | En attente / non publié | University of South Carolina | Israel · Abarbanel MHC, Bat Yam, Israel | 2008-04 → 2010-05 | Ouvrir |
| NCT00411580 Safety and Tolerability Study in Patients With Mild to Moderate Alzheim… |
CAD106 | Alzheimer | Phase 1 | COMPLETED | En attente / non publié | Novartis Pharmaceuticals | Sweden · Novartis Investigative Site, Malmö, Sweden |… | 2005-06 → 2008-12 | Ouvrir |
| NCT00001480 The Evaluation and Follow-up of Individuals With Memory Disorder |
The Evaluation and Follow-up of I… | Alzheimer | À vérifier | COMPLETED | En attente / non publié | National Institute of Mental Heal… | United States · Catholic University of America, Washi… | 1995-03-21 → 2007-03-31 | Ouvrir |
| NCT07371338 Phase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacoki… |
IPS101A | Parkinson | Phase 1 | RECRUITING | En attente / non publié | Innopeutics Corporation | South Korea · Severance Hospital, Seoul, South Korea | 2026-05-30 → 2027-12-31 | Ouvrir |
| NCT06206538 Efficacy of Stellate Ganglion Block in Patients With Parkinson's Disease |
Stellate ganglion block | Parkinson | NA | WITHDRAWN | En attente / non publié | People's Hospital of Zhengzhou Un… | China · Zheng Da yi Yuan Hospital, Zhengzhou, China | 2024-01-15 → 2024-04-10 | Ouvrir |
| NCT02542696 Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability … |
APL-130277 | Parkinson | Phase 3 | COMPLETED | En attente / non publié | Sumitomo Pharma America, Inc. | United States, Austria, Canada, France, Germany, Ital… | 2015-08-31 → 2022-11-08 | Ouvrir |
| NCT03189459 In-Home Care for Patients With Parkinson's Disease |
In-Home Care for Patients With Pa… | Parkinson | NA | COMPLETED | En attente / non publié | Rush University Medical Center | United States · Rush University Medical Center, Chica… | 2018-05-07 → 2021-12-31 | Ouvrir |
| NCT03959540 Safety and Effectiveness of Opicapone Plus Standard of Care in Elderly … |
Opicapone | Parkinson | À vérifier | COMPLETED | En attente / non publié | Bial - Portela C S.A. | United Kingdom · Norfolk&Norwich University Hospitals… | 2020-04-28 → 2021-05-11 | Ouvrir |
| NCT07606521 A Biosimilar Trial to Investigate PK, PD, Safety With PB018 Versus US-l… |
US-Ocrevus | SEP | Phase 1 | NOT_YET_RECRUITING | En attente / non publié | Polpharma Biologics International… | Non communiqué | 2026-10 → 2028-04 | Ouvrir |
| NCT04548999 GAVOTTE — A Study to Evaluate the Efficacy, Safety and Pharmacokinetics… |
Ocrelizumab | SEP | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | Hoffmann-La Roche | United States, Argentina, Belgium, Brazil, Bulgaria, … | 2020-12-03 → 2027-09-08 | Ouvrir |
| NCT01412333 A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in… |
Interferon beta-1a | SEP | Phase 3 | COMPLETED | En attente / non publié | German University in Cairo | United States, Argentina, Belarus, Belgium, Bosnia an… | 2011-09-20 → 2022-12-30 | Ouvrir |
| NCT02753088 Efficacy and Safety of BCD-063 and Copaxone-Teva in Patients With Relap… |
BCD-063 | SEP | Phase 3 | COMPLETED | En attente / non publié | Biocad | Non communiqué | 2013-10 → 2015-11 | Ouvrir |
| NCT00477113 TYGRIS — TYSABRI Global Observational Program in Safety |
TYGRIS — TYSABRI Global Observati… | SEP | À vérifier | COMPLETED | En attente / non publié | Biogen | United States · There may be mulitple sites in this c… | 2007-01 → 2015-05 | Ouvrir |
| NCT00856518 EMST — Expiratory Muscle Training for Persons With Neurodegenerative Di… |
EMST | SEP | Phase 2 | COMPLETED | En attente / non publié | VA Office of Research and Develop… | United States · North Florida/South Georgia Veterans … | 2009-03 → 2014-08 | Ouvrir |
| NCT07672535 Inspiratory Muscle Training in Individuals With Multiple Sclerosis |
Inspiratory Muscle Training in In… | SEP | NA | NOT_YET_RECRUITING | En attente / non publié | Istanbul University - Cerrahpasa | Non communiqué | 2026-08 → 2028-01 | Ouvrir |
| NCT00291148 Neuropathic Pain Assessment Comparing Pregabalin and Paroxetine in Mana… |
paroxetine | SEP | Phase 3 | COMPLETED | En attente / non publié | University of California, Irvine | Canada · Multiple Sclerosis Clinic, Health Sciences C… | 2006-03 → 2012-07 | Ouvrir |
| NCT04719403 Determining Feasibility and Acceptability of Sharing Video Recordings W… |
Determining Feasibility and Accep… | Sclérose latérale amyotrophique | NA | COMPLETED | En attente / non publié | Dartmouth-Hitchcock Medical Center | United States · Dartmouth-Hitchcock Medical Center, L… | 2021-05-12 → 2022-06-09 | Ouvrir |
| NCT00846560 Involvement of Lymphocyte Type B in Amyotrophic Lateral Sclerosis (ALS) |
Involvement of Lymphocyte Type B … | Sclérose latérale amyotrophique | À vérifier | WITHDRAWN | En attente / non publié | Rambam Health Care Campus | Israel · Rambam Medical center, Neurology Department,… | 2008-08 → 2009-07 | Ouvrir |
| NCT05039268 3K3A-APC for Treatment of Amyotrophic Lateral Sclerosis (ALS) |
3K3A-APC Protein | Sclérose latérale amyotrophique | Phase 2 | COMPLETED | En attente / non publié | Macquarie University, Australia | Australia · Macquarie University, Macquarie Park, Aus… | 2021-11-25 → 2022-09-12 | Ouvrir |
| NCT07396818 Kamlanoflast In Amyotrophic Lateral Sclerosis |
Kamlanoflast | Sclérose latérale amyotrophique | Phase 1 | NOT_YET_RECRUITING | En attente / non publié | Inflammasome Therapeutics | Non communiqué | 2026-02 → 2027-01 | Ouvrir |
| NCT06471361 A Study to Evaluate the Safe and Effective Use of a Zilucoplan Auto-inj… |
Zilucoplan | Myasthénie | Phase 3 | COMPLETED | En attente / non publié | UCB Biopharma SRL | United States, Poland, United Kingdom · Dv0013 40605,… | 2024-08-27 → 2025-02-03 | Ouvrir |
| NCT03896295 An Extension Study of MOM-M281-004 to Evaluate the Safety, Tolerability… |
M281 | Myasthénie | Phase 2 | TERMINATED | En attente / non publié | Momenta Pharmaceuticals, Inc. | United States, Belgium, Canada, Germany, Italy, Polan… | 2019-08-06 → 2020-12-09 | Ouvrir |